What are symptoms of hyperglycinemia?

What are symptoms of hyperglycinemia?

Signs of nonketotic hyperglycinemia (NKH) can begin any time from infancy to adulthood and include:

• Sleeping longer or more often.
• Weak muscle tone (also known as hypotonia)
• Wandering eye movements.
• Abnormal jerky movements.
• Difficulty feeding.
• Difficulty breathing.
• Developmental delay.

What causes glycine encephalopathy?

Glycine encephalopathy is caused by changes ( mutations ) in the AMT, GLDC or GCSH genes which result in a deficiency of the enzyme that break-up the glycine. Diagnosis is based in the symptoms, the high glycine levels and the enzyme deficiency, as well as genetic testing . Inheritance is autosomal recessive .

What is the life expectancy of someone with NKH?

However, recent work has reported that patients with a similar clinical presentation, such as severe cerebral palsy, have a life span that reaches the age of 60 years [19]. The message of this work is that children with NKH should not be considered as a severely spastic cerebral palsy patients.

How common is glycine encephalopathy?

Glycine encephalopathy has an estimated incidence of 1 in 60,000, making it the second most common disorder of amino acid metabolism, after phenylketonuria. It is caused by a defect in the glycine cleavage system (GCS), which is made up of four protein subunits.

How common is Nonketotic hyperglycinemia?

Nonketotic hyperglycinemia is estimated to affect at least 1 in 76,000 people worldwide. In Finland, the condition occurs in about 1 in 55,000 newborns, and in British Columbia, Canada, it occurs in about 1 in 63,000 newborns.

How is Nonketotic hyperglycinemia diagnosed?

CSF glycine is the preferred diagnostic test. Molecular analysis is an excellent confirmatory test. With sequencing and deletion/duplication analysis, 98% of alleles are detected. Brain MRI imaging can also be helpful because there is a specific pattern of changes seen in individuals with NKH.

What causes hyperglycinemia?

Mutations in the GLDC or AMT gene cause nonketotic hyperglycinemia. About 80 percent of cases result from mutations in the GLDC gene, while AMT gene mutations cause about 20 percent of all cases. The GLDC and AMT genes provide instructions for making enzymes that work together as a group.

What is transient glycine encephalopathy?

Transient glycine encephalopathy was the term used initially to describe the findings in seven neonates [Boneh et al 1996] who presented with seizures and/or a burst suppression pattern on EEG. All had the biochemical features of glycine encephalopathy, which then resolved.

What is non-ketotic hyperglycinemia?

Nonketotic hyperglycinemia is a disorder characterized by abnormally high levels of a molecule called glycine in the body (hyperglycinemia). The excess glycine builds up in tissues and organs, particularly the brain.

What are the diagnostic tests for glycine encephalopathy (CE)?

If glycine encephalopathy is clinically suspected, the following diagnostic testing algorithm is recommended: First tier testing should consist of biochemical screening including measurement of glycine levels in both plasma and CSF. Urine organic acid analysis should also be performed to exclude ketotic hyperglycinemia.

How is excess glycine treated in diabetic neuropathy?

Thus, the excess glycine concentration can potentially impair neurogenesis and produce cellular neurotoxicity. Patients are treated with sodium benzoate to reduce glycine levels in the blood and CSF, and with dextromethorphan to counteract the neurostimulatory effect of high glycine levels on NMDA receptors.